Peptides for Gut Health – BPC-157, KPV, Larazotide, TB-500, LL-37, TB4, GHK-Cu
A comprehensive review of the most effective peptides for gastrointestinal integrity. Exploring BPC-157, KPV, Larazotide, and GHK-Cu for treating leaky gut, colitis, and microbiome dysbiosis.
Table of Contents
Introduction to Gut Health Peptides
The gastrointestinal tract is a complex system involving the mucosal barrier, microbiome, and immune system. Research has identified several peptides that play critical roles in maintaining and repairing gut integrity. This article reviews the science behind key peptides like BPC-157, KPV, Larazotide, and GHK-Cu in the context of gut health.
BPC-157: The Body Protection Compound
Hypogastric (Stable) BPC-157 is perhaps the most well-researched peptide for gut health. Derived from a protein found in gastric juice, it exhibits profound cytoprotective effects.
Mechanisms of Action
- Angiogenesis: BPC-157 stimulates the formation of new blood vessels via the VEGF pathway, which is crucial for healing damaged tissue in the gut lining.
- Anti-Inflammatory: It interacts with the NO system to modulate inflammation, reducing damage in models of colitis and inflammatory bowel disease (IBD).
- Fistula Healing: Unique among peptides, BPC-157 has demonstrated the ability to promote the healing of various fistulas (rectovaginal, enterocutaneous) in animal models.
KPV: The Anti-Inflammatory Tripeptide
KPV (Lysine-Proline-Valine) is a C-terminal fragment of Alpha-MSH. It is known for its potent anti-inflammatory and antimicrobial properties.
Research Findings
- NF-κB Inhibition: KPV inhibits the NF-κB pathway, a central regulator of inflammation. This makes it a candidate for treating inflammatory conditions like ulcerative colitis.
- Antimicrobial Activity: It shows activity against pathogens like S. aureus and C. albicans, potentially helping to balance the gut microbiome.
Larazotide (AT-1001): Restoring the Barrier
Larazotide acetate represents a novel class of therapeutic specifically designed to repair "leaky gut" by regulating tight junctions.
Mechanism
- Larazotide functions as a zonulin antagonist. Zonulin is a protein that opens tight junctions between intestinal cells. By blocking zonulin, Larazotide helps keep these junctions closed, restoring intestinal barrier function and preventing the passage of toxins and antigens into the bloodstream.
- It is currently in Phase 3 clinical trials for Celiac disease.
GHK-Cu in the Gut
While famous for skin repair, GHK-Cu also plays a role in the GI tract.
- Tissue Remodeling: Its ability to stimulate collagen synthesis and remodel tissue is applicable to healing ulcers and intestinal damage.
- Anti-Cancer Potential: Some research suggests GHK-Cu can restore healthy gene expression patterns in colon cancer cells.
Conclusion
Peptides offer a targeted approach to gut health, addressing issues from inflammation (KPV) to structural repair (BPC-157, Larazotide). Continued research elucidates their potential as therapeutic agents for gastrointestinal disorders.
References
[1] Sikiric P, et al. "Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease." Current Pharmaceutical Design. 2013. [2] Dalmasso G, et al. "PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation." Gastroenterology. 2008. [3] Leffler DA, et al. "Larazotide acetate for persistent symptoms of celiac disease." Gastroenterology. 2015.